IMMCO DIAGNOSTICS, INC. – Trademark Portfolio
Entity Type: 03
IMMCO DIAGNOSTICS, INC. owns a portfolio of 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as IMMUGLO, IMMULISA, and IMMCO DIAGNOSTICS. Of these, 3 are registered. The portfolio spans 5 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 42 (Computer & Scientific). Headquartered in BUFFALO, NY.
963 KENMORE AVENUE
BUFFALO, NY 14223
Showing of trademarks Trademarks
Trademark Classifications
IMMCO DIAGNOSTICS, INC.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does IMMCO DIAGNOSTICS, INC. have?
IMMCO DIAGNOSTICS, INC. has 16 U.S. trademarks filed with the USPTO. Of these, 3 registered, 10 abandoned, 3 cancelled.
What trademark classes does IMMCO DIAGNOSTICS, INC. file in?
IMMCO DIAGNOSTICS, INC. files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are IMMCO DIAGNOSTICS, INC.'s most well-known trademarks?
IMMCO DIAGNOSTICS, INC.'s registered trademark portfolio includes well-known marks such as IMMUGLO, IMMULISA, and IMMCO DIAGNOSTICS. These are among 3 currently registered trademarks in the portfolio.
What is IMMCO DIAGNOSTICS, INC.'s trademark registration success rate?
IMMCO DIAGNOSTICS, INC. has a 19% trademark registration rate, with 3 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.